Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Maxxam Analytics Acquires Becquerel Labs | Contract Pharma

What are you searching for?

Sign in
Breaking News

Maxxam Analytics Acquires Becquerel Labs

Enhances technical expertise in radiological testing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Maxxam Analytics has acquired Becquerel Laboratories based in Mississauga, ON. Becquerel provides highly specialized radiological testing and neutron activation testing services. Maxxam does not plan to make any staffing or location changes for Becquerel. Financial terms were not disclosed.
 
Maxxam chief executive officer Jon Hantho said, “The acquisition of Becquerel is an exciting step for Maxxam to further increase the level of technical expertise our clients have access to. Becquerel’s capabilities are at the leading edge of clients’ emerging needs in terms of the environmental regulations we expect to see in the coming years. In essence, this acquisition is a reflection of Maxxam’s on-going commitment to deliver success through science for our clients.”
 
“We’re delighted to become part of Maxxam,” said Steven Simpson, president of Becquerel. “The backing of a company of Maxxam’s caliber will further strengthen our business and enhance our ability to take on large scale projects, without compromising the level of support and technical expertise our clients have come to expect from us.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters